PAR paradigm biopharmaceuticals limited..

Where are we on a deal?, page-1286

  1. 5,011 Posts.
    lightbulb Created with Sketch. 532
    great, the Sharewise interview and the AGM both took place before FDA clearance, with the AGM occurring after the Sharewise interview. Therefore, the updated commentary at the AGM takes precedence over the earlier statements.

    Since in the AGM commentary he stated that he believed a deal would happen in 2025, and knowing that negotiations can take time, I certainly didn’t expect one by now. "I certainly have not been expecting one by now." Based on how long deals typically take, my own guess would be that it might happen later in 2025, if it does at all. This is supported by my earlier comment about being pleasantly surprised if it occurred before Q2. "I'll be pleasantly suprised if a funding deal happens before Q2 CY2025."

    We are still in 2025.

    So why did you say, "You state you are not expecting a deal, and I find that strange," when you know I actually said, "I certainly have not been expecting one by now" which you even quoted?

    And why are you disregarding the AGM commentary and fixating on your interpretation of the outdated remarks remarks when that may lead to confusion and could be misinterpreted as an instance of PR overpromising or misleading shareholders.
    Last edited by asx11: 29/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.0¢
Change
-0.015(4.48%)
Mkt cap ! $122.6M
Open High Low Value Volume
33.5¢ 34.0¢ 31.5¢ $215.7K 663.5K

Buyers (Bids)

No. Vol. Price($)
3 30081 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 10905 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.